drugset / Trial / NCT00579020
A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether Moxidex ophthalmic solution is safe and effective in treating marginal corneal infiltrates.
Timeline
- Start
- 2007-12
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 0.1 % | Topical |
| Comparator | Moxifloxacin | Small molecule | 0.5 % | Topical |
| Subject | Moxifloxacin/dexamethasone phosphate | Unknown | — | Topical |